A first-in-human phase 1 study of the safety and pharmacokinetics of XB002 in patients with inoperable locally advanced or metastatic solid tumors.

被引：0
|
作者：
Johnson, Melissa [1 ]
Ulahannan, Susanna [2 ]
Vandross, Andrae [3 ]
Park, Haeseong [4 ]
Faoro, Leo [5 ]
Faggioni, Raffaella [5 ]
Li, Jing [5 ]
Chang, Yu-Lin [5 ]
Uttamsingh, Shailaja [5 ]
Tolcher, Anthony [6 ]
机构：
[1] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[2] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK USA
[3] NEXT Oncol, Austin, TX USA
[4] Washington Univ, St Louis, MO 63110 USA
[5] Exelixis Inc, Alameda, CA USA
[6] NEXT Oncol, San Antonio, TX USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT254
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 in subjects with inoperable locally advanced or metastatic solid tumors
    Tolcher, Anthony
    Vandross, Andrae
    Johnson, Melissa
    Park, Haeseong
    Scheffold, Christian
    Li, Jing
    Bekele, Neby
    Uttamsingh, Shailaja
    Faggioni, Raffaella
    Ulahannan, Susanna
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S158 - S158
  • [2] Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors.
    Powderly, John
    Shimizu, Toshio
    LoRusso, Patricia
    Razak, Albiruni
    Miller, Kathy
    Balar, Arjun
    Bruix, Jordi
    Michel, Loren
    Blaney, Martha
    Guan, Xiaowen
    Lacy, Susan
    Lally, Satwant
    Lambert, Stacie
    Leibman, Rachel
    Vosganian, Gregory
    Golan, Talia
    Tolcher, Anthony
    CANCER RESEARCH, 2021, 81 (13)
  • [3] First-in-human phase 1 study of DS-1062a in patients with advanced solid tumors.
    Sands, Jacob M.
    Shimizu, Toshio
    Garon, Edward B.
    Greenberg, Jonathan
    Guevara, Ferdinand M.
    Heist, Rebecca Suk
    Kobayashi, Fumiaki
    Noguchi, Yutaka
    Okajima, Daisuke
    Tajima, Naoyuki
    Spira, Alexander I.
    Yamamoto, Noboru
    Lisberg, Aaron Elliott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] A first-in-human, phase 1/2 trial of FOG-001, a β-catenin:TCF antagonist, in patients with locally advanced or metastatic solid tumors.
    Papadopoulos, Kyriakos P.
    Ahnert, Jordi Rodon
    Khushman, Moh'd M.
    Sharma, Sunil
    Pelster, Meredith
    Cecchini, Michael
    Kummar, Shivaani
    Choi, Minjung
    Akella, Lalith V.
    Garofalo, Amanda
    Yu, Ziyang
    Iyer, Varsha
    Nguyen, Marie Huong
    Orford, Keith W.
    Klempner, Samuel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] First-in-human study of PM14 in patients with advanced solid tumors.
    Vieito, Maria
    Aix, Santiago Ponce
    Paz-Ares, Luis G.
    Bahleda, Rastilav
    Massard, Christophe
    Agreda, Leyre
    Banus, Eva
    Fernandez, Cristian Marcelo
    Cristoveanu, Elena Y.
    Corral, Gema
    Llanero, Lourdes
    Lubomirov, Rubin
    Kahatt, Carmen Maria
    Fudio, Salvador
    Nieto, Antonio
    Cullell-Young, Martin
    Zeaiter, Ali Hassan
    Oberoi, Honey Kumar
    Garralda, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of TT125-802 in patients with advanced solid tumors.
    Boni, Valentina
    Garralda, Elena
    Colombo, Ilaria
    Homicsko, Krisztian
    Brana, Irene
    Gruber, Dorothea
    Fluckiger-Mangual, Stefanie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
    El-Khoueiry, Anthony B.
    Ning, Yan
    Yang, Dongyun
    Cole, Sarah
    Kahn, Michael
    Zoghbi, Marwan
    Berg, Jennifer
    Fujimori, Masamoto
    Inada, Tetsuhi
    Kouji, Hiroyuki
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] TRIAL IN PROGRESS: PHASE 1 FIRST-IN-HUMAN STUDY OF XL092 ADMINISTERED ALONE OR IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
    Patnaik, Amita
    Subbiah, Vivek
    Shapiro, Geoffrey
    Pal, Sumanta
    Agarwal, Neeraj
    Wentzel, Kristopher
    Li, Jing
    McIlvaine, Elizabeth
    Waldes, Jana
    Cha, Edward
    Tadjalli-Mehr, Keyvan
    Sharma, Manish
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A544 - A544
  • [9] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] A phase I, first-in-human study of DS-1471 in patients with advanced/metastatic solid tumors
    Koganemaru, S.
    Yoshizuka, N.
    Mizuno, S.
    Hirai, S.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S531 - S531
12345